COR — Cencora Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual income statement for Cencora, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th	2026 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	PRESS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Preliminary
Revenue
Total Revenue	238,587	262,173	293,959	321,333	337,397
Cost of Revenue
Gross Profit	8,335	8,807	9,793	11,292	13,868
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	236,176	259,792	291,783	318,704	333,467
Operating Profit	2,411	2,381	2,175	2,629	3,930
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,183	2,161	2,004	2,258	4,581
Provision for Income Taxes
Net Income After Taxes	1,667	1,733	1,519	1,568	3,501
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,699	1,745	1,509	1,554	3,484
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,699	1,745	1,509	1,554	3,484
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	9.42	9.13	10.8	11.9	21.1
Dividends per Share